ArticleVaccines2022

SARS-CoV-2 Antibody and T Cell Response after a Third Vaccine Dose in Hemodialysis Patients Compared with Healthy Controls.

Benedikt Simon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.